Phase II randomized study of nemorubicin hydrochloride (PNU-152243A) or doxorubicin administered in adult patients with unresectable hepatocellular carcinoma

Update Il y a 5 ans
Reference: EUCTR2006-000798-31

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Evaluation of the survival rate at 7 months


Inclusion criteria

  • Hepatocellular carcinoma